Pharma Mar, S.A. (PHMMF)
USD 81.07
(0.0%)
USD 81.07
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -13.44 Million | 38.32 Million | 25.67 Million | 278.94 Million | -26.13 Million | -16.34 Million |
| Net Income | 1.13 Million | 43.79 Million | 95.12 Million | 145.6 Million | -23.32 Million | -7.68 Million |
| Depreciation & Amortization | 5.75 Million | 5.9 Million | 5.58 Million | 7.21 Million | 6.05 Million | 6.86 Million |
| Deferred income taxes | -19.74 Million | 14.66 Million | -16.78 Million | -4.47 Million | 799 Thousand | 2.68 Million |
| Stock-based compensation | 297 Thousand | 393 Thousand | 339 Thousand | 274 Thousand | 265 Thousand | 795 Thousand |
| Change in working capital | -34.92 Million | -28.22 Million | -61.4 Million | 127.94 Million | -13.58 Million | -13.29 Million |
| Other non-cash items | 34.03 Million | 1.79 Million | 2.81 Million | 2.38 Million | 3.64 Million | -5.69 Million |
| Investing Cash Flow | -43.04 Million | 10.87 Million | 18.47 Million | -119 Million | 32.06 Million | 22.25 Million |
| Investments in PPE | -15.95 Million | -8.85 Million | -7.8 Million | -3 Million | -3.91 Million | -2.37 Million |
| Acquisitions | 27.09 Million | 11 Thousand | - | - | 33.38 Million | 21.25 Million |
| Investment purchases | -314.32 Million | -219.19 Million | - | -116 Million | -70 Thousand | -4000.00 |
| Sales/Maturities of investments | 287.23 Million | 238.91 Million | 26.27 Million | - | 3.91 Million | - |
| Other Investing Activities | -27.09 Million | 19.73 Million | 26.27 Million | -116 Million | -1.24 Million | 3.37 Million |
| Financing Cash Flow | -32.13 Million | -13.37 Million | -27.41 Million | -73.82 Million | -11.03 Million | -7.25 Million |
| Debt repayment | -1.15 Million | -10.2 Million | -15.27 Million | -32.37 Million | -16.91 Million | -16.82 Million |
| Dividends payments | -11.68 Million | -11.76 Million | -10.87 Million | -8.81 Million | - | - |
| Common Stock Repurchased | -37.9 Million | -50.17 Million | -40.65 Million | -63.7 Million | -7.48 Million | -3.44 Million |
| Common Stock Issuance | 18.6 Million | 57.22 Million | 33.55 Million | 30.36 Million | 8.56 Million | 2.78 Million |
| Other Financing Activities | 18.6 Million | 1.54 Million | 5.83 Million | 714 Thousand | 4.79 Million | 17.14 Million |
| Accounts receivables | 1.78 Million | 21.61 Million | -26.76 Million | -12.63 Million | -16.52 Million | 3.3 Million |
| Accounts payables | 1.82 Million | 1.78 Million | 7.18 Million | 4.65 Million | 5.49 Million | 551 Thousand |
| Inventory | -11.54 Million | -17.21 Million | 1.39 Million | -3.03 Million | -2.41 Million | -2.02 Million |
| Other working capital | -26.98 Million | -34.4 Million | -43.23 Million | 138.94 Million | -142 Thousand | -11.26 Million |
| Cash at beginning of period | 149.81 Million | 113.34 Million | 96.21 Million | 17.63 Million | 22.74 Million | 24.08 Million |
| Cash at end of period | 60.02 Million | 149.81 Million | 113.34 Million | 96.21 Million | 17.63 Million | 22.74 Million |
| Capital Expenditure | -15.95 Million | -8.85 Million | -7.8 Million | -3 Million | -3.91 Million | -2.37 Million |
| Effect of forex changes on cash | -1.15 Million | 636 Thousand | 404 Thousand | -7.54 Million | - | - |
| Net cash flow / Change in cash | -89.78 Million | 36.46 Million | 17.13 Million | 78.57 Million | -5.1 Million | -1.34 Million |
| Free Cash Flow | -29.4 Million | 29.46 Million | 17.87 Million | 275.94 Million | -30.04 Million | -18.71 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 3.88 Million | 1.23 Million | 2.3 Million | 1.13 Million | -6.81 Million | 1.56 Million |
| Depreciation & Amortization | 1.54 Million | 1.55 Million | 1.54 Million | 5.75 Million | 1.49 Million | 1.48 Million |
| Deferred income taxes | - | - | - | -19.74 Million | 5.77 Million | -430 Thousand |
| Stock-based compensation | 79 Thousand | 78 Thousand | 80 Thousand | 297 Thousand | 81 Thousand | 82 Thousand |
| Change in working capital | -3.45 Million | -11.96 Million | -4.14 Million | -34.92 Million | 56 Thousand | -8.95 Million |
| Other non-cash items | 2.19 Million | 9.4 Million | 16.61 Million | 34.03 Million | -3.27 Million | -739 Thousand |
| Investing Cash Flow | 927 Thousand | 6.68 Million | -26.98 Million | -43.04 Million | 1.66 Million | 6.17 Million |
| Investments in PPE | -3.69 Million | -2.62 Million | -7.28 Million | -15.95 Million | -5.7 Million | -4.52 Million |
| Acquisitions | - | 477 Thousand | - | 27.09 Million | -7.36 Million | -10.7 Million |
| Investment purchases | -67.05 Million | -101.94 Million | -92.04 Million | -314.32 Million | 10.65 Million | -78.59 Million |
| Sales/Maturities of investments | 72.15 Million | 110.78 Million | 72.34 Million | 287.23 Million | -3.28 Million | 89.29 Million |
| Other Investing Activities | -477 Thousand | 9.31 Million | -19.69 Million | -27.09 Million | 7.36 Million | 10.7 Million |
| Financing Cash Flow | 10.77 Million | -13.6 Million | -6.72 Million | -32.13 Million | -6.31 Million | -6.42 Million |
| Debt repayment | -13.96 Million | -998 Thousand | -3.58 Million | -1.15 Million | -309 Thousand | -1.1 Million |
| Dividends payments | - | -11.42 Million | - | -11.68 Million | - | - |
| Common Stock Repurchased | -3.19 Million | -1.9 Million | -5.07 Million | -37.9 Million | -6 Million | -8 Million |
| Common Stock Issuance | - | 714 Thousand | 1.93 Million | 18.6 Million | - | 2.25 Million |
| Other Financing Activities | - | 1.12 Million | 1.93 Million | 18.6 Million | - | 430 Thousand |
| Accounts receivables | -3.56 Million | -3.2 Million | 610 Thousand | 1.78 Million | 2.62 Million | -3.7 Million |
| Accounts payables | - | 637 Thousand | -346 Thousand | 1.82 Million | 10.62 Million | -577 Thousand |
| Inventory | -513 Thousand | -3.77 Million | -4.19 Million | -11.54 Million | -4.39 Million | 666 Thousand |
| Other working capital | 618 Thousand | -5.63 Million | -215 Thousand | -26.98 Million | -8.79 Million | -5.34 Million |
| Cash at beginning of period | 19.31 Million | 35.7 Million | 60.02 Million | 149.81 Million | 69.97 Million | 76.07 Million |
| Cash at end of period | 34.8 Million | 19.31 Million | 35.7 Million | 60.02 Million | 60.02 Million | 69.97 Million |
| Capital Expenditure | -3.69 Million | -2.62 Million | -7.28 Million | -15.95 Million | -5.7 Million | -4.52 Million |
| Effect of forex changes on cash | -461 Thousand | -258 Thousand | 89 Thousand | -1.15 Million | -2.61 Million | 1.13 Million |
| Net cash flow / Change in cash | 15.48 Million | -16.39 Million | -24.31 Million | -89.78 Million | -9.95 Million | -6.09 Million |
| Free Cash Flow | 547 Thousand | -11.84 Million | 2.01 Million | -29.4 Million | -8.39 Million | -11.51 Million |
SYH
0401
DSFGY
HRNNF
600804
0JR2